Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hybrid peptides as platform for synchronized combination therapy

Colloids and Surfaces B Biointerfaces(2023)10.1016/j.colsurfb.2023.113326Source: DataRank Database

Hybrid peptides as platform for synchronized combination therapy is a research paper published in Colloids and Surfaces B Biointerfaces (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.31)OA: hybridTopics (67)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Tanner Perez ORCID,Luladey Ayalew,Venus Gorbanwand,Joel Monroy,Katarzyna Slowinska ORCID

Live enrichment

PubMed:37116378 PMC:PMC10247525 OpenAlex:https://openalex.org/W4366815074

National Institutes of Health

Grant: T34 GM008074

National Institute of General Medical Sciences

Grant: GM099594

NIGMS NIH HHS

Grant: T34 GM149378

NIGMS NIH HHS

Grant: SC3 GM099594

National Institutes of Health

Grant: 5T34GM008074-08

MARC UNDERGRADUATE RESEARCH TRAINING PROGRAM

Tufts University

FWCI

0.31

Citation Percentile

0.5%

Citation Trend

2023

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.colsurfb.2023.113326

publisherhttps://doi.org/10.1016/j.colsurfb.2023.113326

publisherhttps://api.elsevier.com/content/article/PII:S0927776523002047?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0927776523002047?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37116378

Fields of Study

Collagen: Extraction and CharacterizationSilk-based biomaterials and applicationsChemical Synthesis and Analysis02 engineering and technology0210 nano-technologyHumansFemaleTissue DistributionPaclitaxelPeptidesDrug Delivery SystemsDoxorubicinBreast NeoplasmsNanoparticlesFluorouracilCollagenCell Line, TumorCell-Penetrating Peptides

MeSH Terms

Breast NeoplasmsCollagenDoxorubicinFemaleFluorouracilHumansPeptidesTissue DistributionDrug Delivery SystemsPaclitaxelCell Line, TumorNanoparticlesCell-Penetrating Peptides

Keywords

PaclitaxelDoxorubicinPeptideCombination therapyDrug deliveryDrugBiodistributionTargeted drug deliveryTargeted therapyCell-penetrating peptideChemistryNanotechnologyPharmacologyMaterials scienceCancer researchCancerMedicineBiochemistryIn vitroChemotherapyInternal medicineCodeliveryHybrid PeptidesPeptide NanoparticleHeterotrimer PeptidesBreast NeoplasmsCell-Penetrating PeptidesDrug Delivery SystemsCell Line, TumorHumansNanoparticlesFemaleTissue DistributionFluorouracilCollagenPeptides

Sustainable Development Goals

SDG 0: Good health and well-being

Hybrid peptides as platform for synchronized combination therapy

FAIR Checklist

Authors (6)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)